Strategies for measurement of atmospheric column means of carbon dioxide from aircraft using discrete sampling

[1] Automated flask sampling aboard small charter aircraft has been proposed as a low-cost, reliable method to greatly increase the density of measurements of CO2 mixing ratios in continental regions in order to provide data for assessment of global and regional CO2 budgets. We use data from the CO2 Budget and Rectification-Airborne 2000 campaign over North America to study the feasibility of using discrete ( flask) sampling to determine column mean CO2 in the lowest 4 km of the atmosphere. To simulate flask sampling, data were selected from profiles of CO2 measured continuously with an onboard ( in situ) analyzer. We find that midday column means can be determined without bias relative to true column means measured by the in situ analyzer to within 0.15 and better than 0.10 ppm by using 10 and 20 instantaneously collected flask samples, respectively. More precise results can be obtained by using a flask sampling strategy that linearly integrates over portions of the air column. Using less than 8 - 10 flasks can lead to significant sampling bias for some common profile shapes. Sampling prior to the breakup of the nocturnal stable layer will generally lead to large sampling bias because of the inability of aircraft to probe large CO2 gradients that often exist very close to the ground at night and during the early morning

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer : a systematic review and overview of reviews

Background: Prophylactic aspirin has been considered to be beneficial in reducing the risks of heart disease and cancer. However, potential benefits must be balanced against the possible harm from side effects, such as bleeding and gastrointestinal (GI) symptoms. It is particularly important to know the risk of side effects when aspirin is used as primary prevention - that is when used by people as yet free of, but at risk of developing, cardiovascular disease (CVD) or cancer. In this report we aim to identify and re-analyse randomised controlled trials (RCTs), systematic reviews and meta-analyses to summarise the current scientific evidence with a focus on possible harms of prophylactic aspirin in primary prevention of CVD and cancer. Objectives: To identify RCTs, systematic reviews and meta-analyses of RCTs of the prophylactic use of aspirin in primary prevention of CVD or cancer. To undertake a quality assessment of identified systematic reviews and meta-analyses using meta-analysis to investigate study-level effects on estimates of benefits and risks of adverse events; cumulative meta-analysis; exploratory multivariable meta-regression; and to quantify relative and absolute risks and benefits. Methods: We identified RCTs, meta-analyses and systematic reviews, and searched electronic bibliographic databases (from 2008 September 2012) including MEDLINE, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, NHS Centre for Reviews and Dissemination, and Science Citation Index. We limited searches to publications since 2008, based on timing of the most recent comprehensive systematic reviews. Results: In total, 2572 potentially relevant papers were identified and 27 met the inclusion criteria. Benefits of aspirin ranged from 6% reduction in relative risk (RR) for all-cause mortality [RR 0.94, 95% confidence interval (CI) 0.88 to 1.00] and 10% reduction in major cardiovascular events (MCEs) (RR 0.90, 95% CI 0.85 to 0.96) to a reduction in total coronary heart disease (CHD) of 15% (RR 0.85, 95% CI 0.69 to 1.06). Reported pooled odds ratios (ORs) for total cancer mortality ranged between 0.76 (95% CI 0.66 to 0.88) and 0.93 (95% CI 0.84 to 1.03). Inclusion of the Women's Health Study changed the estimated OR to 0.82 (95% CI 0.69 to 0.97). Aspirin reduced reported colorectal cancer (CRC) incidence (OR 0.66, 95% CI 0.90 to 1.02). However, including studies in which aspirin was given every other day raised the OR to 0.91 (95% CI 0.74 to 1.11). Reported cancer benefits appeared approximately 5 years from start of treatment. Calculation of absolute effects per 100,000 patient-years of follow-up showed reductions ranging from 33 to 46 deaths (all-cause mortality), 60-84 MCEs and 47-64 incidents of CHD and a possible avoidance of 34 deaths from CRC. Reported increased RRs of adverse events from aspirin use were 37% for GI bleeding (RR 1.37, 95% CI 1.15 to 1.62), between 54% (RR 1.54, 95% CI 1.30 to 1.82) and 62% (RR 1.62, 95% CI 1.31 to 2.00) for major bleeds, and between 32% (RR 1.32, 95% CI 1.00 to 1.74) and 38% (RR 1.38, 95% CI 1.01 to 1.82) for haemorrhagic stroke. Pooled estimates of increased RR for bleeding remained stable across trials conducted over several decades. Estimates of absolute rates of harm from aspirin use, per 100,000 patient-years of follow-up, were 99-178 for non-trivial bleeds, 46-49 for major bleeds, 68-117 for GI bleeds and 8-10 for haemorrhagic stroke. Meta-analyses aimed at judging risk of bleed according to sex and in individuals with diabetes were insufficiently powered for firm conclusions to be drawn. Limitations: Searches were date limited to 2008 because of the intense interest that this subject has generated and the cataloguing of all primary research in so many previous systematic reviews. A further limitation was our potential over-reliance on study-level systematic reviews in which the person-years of follow-up were not accurately ascertainable. However, estimates of number of events averted or incurred through aspirin use calculated from data in study-level meta-analyses did not differ substantially from estimates based on individual patient data-level meta-analyses, for which person-years of follow-up were more accurate (although based on less-than-complete assemblies of currently available primary studies). Conclusions: We have found that there is a fine balance between benefits and risks from regular aspirin use in primary prevention of CVD. Effects on cancer prevention have a long lead time and are at present reliant on post hoc analyses. All absolute effects are relatively small compared with the burden of these diseases. Several potentially relevant ongoing trials will be completed between 2013 and 2019, which may clarify the extent of benefit of aspirin in reducing cancer incidence and mortality. Future research considerations include expanding the use of IPD meta-analysis of RCTs by pooling data from available studies and investigating the impact of different dose regimens on cardiovascular and cancer outcomes

Power-Based Droop Control in DC Microgrids Enabling Seamless Disconnection From Upstream Grids

This paper proposes a local power-based droop controller for distributed energy resource converters in dc microgrids that are connected to upstream grids by grid-interface converters. During normal operation, the grid-interface converter imposes the microgrid bus voltage, and the proposed controller allows power flow regulation at distributed energy resource converters\u2019 output. On the other hand, during abnormal operation of the grid-interface converter (e.g., due to faults in the upstream grid), the proposed controller allows bus voltage regulation by droop control. Notably, the controller can autonomously convert from power flow control to droop control, without any need of bus voltage variation detection schemes or communication with other microgrid components, which enables seamless transitions between these two modes of operation. Considering distributed energy resource converters employing the power-based droop control, the operation modes of a single converter and of the whole microgrid are defined and investigated herein. The controller design is also introduced. Furthermore, the power sharing performance of this control approach is analyzed and compared with that of classical droop control. The experimental results from a laboratory-scale dc microgrid prototype are reported to show the final performances of the proposed power-based droop control

Precision requirements for space-based XCO2 data

Author Posting. © American Geophysical Union, 2007. This article is posted here by permission of American Geophysical Union for personal use, not for redistribution. The definitive version was published in Journal of Geophysical Research 112 (2007): D10314, doi:10.1029/2006JD007659.Precision requirements are determined for space-based column-averaged CO2 dry air mole fraction (XCO2) data. These requirements result from an assessment of spatial and temporal gradients in XCO2, the relationship between XCO2 precision and surface CO2 flux uncertainties inferred from inversions of the XCO2 data, and the effects of XCO2 biases on the fidelity of CO2 flux inversions. Observational system simulation experiments and synthesis inversion modeling demonstrate that the Orbiting Carbon Observatory mission design and sampling strategy provide the means to achieve these XCO2 data precision requirements.This work was supported by the Orbiting Carbon Observatory (OCO) project through NASA’s Earth System Science Pathfinder (ESSP) program. SCO and JTR were supported by a NASA IDS grant (NAG5-9462) to JTR

Zoonotic hepatitis E: animal reservoirs and emerging risks

Hepatitis E virus (HEV) is responsible for enterically-transmitted acute hepatitis in humans with two distinct epidemiological patterns. In endemic regions, large waterborne epidemics with thousands of people affected have been observed, and, in contrast, in non-endemic regions, sporadic cases have been described. Although contaminated water has been well documented as the source of infection in endemic regions, the modes of transmission in non-endemic regions are much less known. HEV is a single-strand, positive-sense RNA virus which is classified in the Hepeviridae family with at least four known main genotypes (1–4) of mammalian HEV and one avian HEV. HEV is unique among the known hepatitis viruses, in which it has an animal reservoir. In contrast to humans, swine and other mammalian animal species infected by HEV generally remain asymptomatic, whereas chickens infected by avian HEV may develop a disease known as Hepatitis-Splenomegaly syndrome. HEV genotypes 1 and 2 are found exclusively in humans while genotypes 3 and 4 are found both in humans and other mammals. Several lines of evidence indicate that, in some cases involving HEV genotypes 3 and 4, animal to human transmissions occur. Furthermore, individuals with direct contact with animals are at higher risk of HEV infection. Cross-species infections with HEV genotypes 3 and 4 have been demonstrated experimentally. However, not all sources of human infections have been identified thus far and in many cases, the origin of HEV infection in humans remains unknown

Summertime photochemistry of the troposphere at high northern latitudes

The budgets of O, NO (NO+NO), reactive nitrogen (NO), and acetic acid in the 0–6 km column over western Alaska in summer are examined by photochemical modeling of aircraft and ground‐based measurements from the Arctic Boundary Layer Expedition (ABLE 3A). It is found that concentrations of O in the region are regulated mainly by input from the stratosphere, and losses of comparable magnitude from photochemistry and deposition. The concentrations of NO (10–50 ppt) are sufficiently high to slow down O photochemical loss appreciably relative to a NO‐free atmosphere; if no NO were present, the lifetime of O in the 0–6 km column would decrease from 46 to 26 days because of faster photochemical loss. The small amounts of NO present in the Arctic troposphere have thus a major impact on the regional O budget. Decomposition of peroxyacetyl nitrate (PAN) can account for most of the NO below 4‐km altitude, but for only 20% at 6‐km altitude. Decomposition of other organic nitrates might supply the missing source of NO. The lifetime of NO, in the ABLE 3A flight region is estimated at 29 days, implying that organic nitrate precursors of NO could be supplied from distant sources including fossil fuel combustion at northern mid‐latitudes. Biomass fire plumes sampled during ABLE 3A were only marginally enriched in O; this observation is attributed in part to low NO emissions in the fires, and in part to rapid conversion of NO to PAN promoted by low atmospheric temperatures. It appears that fires make little contribution to the regional O budget. Only 30% of the acetic acid concentrations measured during ABLE 3A can be accounted for by reactions of CHCO with HO and CHO. There remains a major unidentified source of acetic acid in the atmosphere.Engineering and Applied Science

Carbon isotope discrimination of arctic and boreal biomes inferred from remote atmospheric measurements and a biosphere-atmosphere model

Estimating discrimination against ^(13)C during photosynthesis at landscape, regional, and biome scales is difficult because of large-scale variability in plant stress, vegetation composition, and photosynthetic pathway. Here we present estimates of ^(13)C discrimination for northern biomes based on a biosphere-atmosphere model and on National Oceanic and Atmospheric Administration Climate Monitoring and Diagnostics Laboratory and Institute of Arctic and Alpine Research remote flask measurements. With our inversion approach, we solved for three ecophysiological parameters of the northern biosphere (^(13)C discrimination, a net primary production light use efficiency, and a temperature sensitivity of heterotrophic respiration (a Q10 factor)) that provided a best fit between modeled and observed δ^(13)C and CO_2. In our analysis we attempted to explicitly correct for fossil fuel emissions, remote C4 ecosystem fluxes, ocean exchange, and isotopic disequilibria of terrestrial heterotrophic respiration caused by the Suess effect. We obtained a photosynthetic discrimination for arctic and boreal biomes between 19.0 and 19.6‰. Our inversion analysis suggests that Q10 and light use efficiency values that minimize the cost function covary. The optimal light use efficiency was 0.47 gC MJ^(−1) photosynthetically active radiation, and the optimal Q10 value was 1.52. Fossil fuel and ocean exchange contributed proportionally more to month-to-month changes in the atmospheric growth rate of δ^(13)C and CO_2 during winter months, suggesting that remote atmospheric observations during the summer may yield more precise estimates of the isotopic composition of the biosphere

Seasonal pattern of regional carbon balance in the central Rocky Mountains from surface and airborne measurements

[1] High-elevation forests represent a large fraction of potential carbon uptake in North America, but this uptake is not well constrained by observations. Additionally, forests in the Rocky Mountains have recently been severely damaged by drought, fire, and insect outbreaks, which have been quantified at local scales but not assessed in terms of carbon uptake at regional scales. The Airborne Carbon in the Mountains Experiment was carried out in 2007 partly to assess carbon uptake in western U.S. mountain ecosystems. The magnitude and seasonal change of carbon uptake were quantified by (1) paired upwind-downwind airborne CO2 observations applied in a boundary layer budget, (2) a spatially explicit ecosystem model constrained using remote sensing and flux tower observations, and (3) a downscaled global tracer transport inversion. Top-down approaches had mean carbon uptake equivalent to flux tower observations at a subalpine forest, while the ecosystem model showed less. The techniques disagreed on temporal evolution. Regional carbon uptake was greatest in the early summer immediately following snowmelt and tended to lessen as the region experienced dry summer conditions. This reduction was more pronounced in the airborne budget and inversion than in flux tower or upscaling, possibly related to lower snow water availability in forests sampled by the aircraft, which were lower in elevation than the tower site. Changes in vegetative greenness associated with insect outbreaks were detected using satellite reflectance observations, but impacts on regional carbon cycling were unclear, highlighting the need to better quantify this emerging disturbance effect on montane forest carbon cycling

Identification of Candidate Genes for Dyslexia Susceptibility on Chromosome 18

Background: Six independent studies have identified linkage to chromosome 18 for developmental dyslexia or general reading ability. Until now, no candidate genes have been identified to explain this linkage. Here, we set out to identify the gene(s) conferring susceptibility by a two stage strategy of linkage and association analysis. Methodology/Principal Findings: Linkage analysis: 264 UK families and 155 US families each containing at least one child diagnosed with dyslexia were genotyped with a dense set of microsatellite markers on chromosome 18. Association analysis: Using a discovery sample of 187 UK families, nearly 3000 SNPs were genotyped across the chromosome 18 dyslexia susceptibility candidate region. Following association analysis, the top ranking SNPs were then genotyped in the remaining samples. The linkage analysis revealed a broad signal that spans approximately 40 Mb from 18p11.2 to 18q12.2. Following the association analysis and subsequent replication attempts, we observed consistent association with the same SNPs in three genes; melanocortin 5 receptor (MC5R), dymeclin (DYM) and neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L). Conclusions: Along with already published biological evidence, MC5R, DYM and NEDD4L make attractive candidates for dyslexia susceptibility genes. However, further replication and functional studies are still required.Publisher PDFPeer reviewe